What is a SARC Center?
A registered SARC Center is an institution, center, or practice that is affiliated with our organization by sharing our commitment to sarcoma research through collaboration. SARC centers are interested in actively working with other SARC constituents in regard to laboratory and/or clinical research.
Interested in being a part of this important work? Join us. After you submit the online survey, which seeks information about your site’s capabilities for conducting sarcoma clinical research, we will contact you via email regarding next steps in the review process.
Please designate a physician from your site as the primary contact when completing the survey.
To be designated as a SARC Center, your institution, center, or practices should meet the following criteria:
- Have a sarcoma clinical or laboratory translational expertise
- Have small to medium size sarcoma programs
- Have interest in participating in SARC clinical trials
- Have interest in participating in SARC scientific leadership
SARC Core Center
To be designated as a SARC Core Center, your institution, center, or practices should meet the following criteria:
- Have sarcoma expertise at a multidisciplinary level (i.e. surgical oncology, medical oncology, pediatric oncology, orthopaedic oncology, radiation therapy, pathology and radiology)
- Have a significant sarcoma program that sees at least 70 new cases of sarcoma annually
- Demonstrate experience in conducting sarcoma clinical research (for the Clinical Research Committee) and/or laboratory translational research (for the Developmental Therapeutics Committee)
SARC International Center
To be designated as a SARC International Center, your institution, center, or practices should meet the following criteria:
- Have sarcoma clinical or laboratory translational expertise
- Be located outside the United States
Participating in SARC Trials
Institutions interested in participating in SARC clinical trials should begin by completing a SARC institutional membership survey which seeks information about your site’s capabilities for conducting sarcoma clinical research. Once the membership survey has been reviewed and approved we will confirm your membership status and provide information regarding upcoming SARC trials.
Trial Budget and Accrual Expectations
Please note that budget limitations or small pilot studies may limit the number of feasible participating sites.
When appropriate and feasible, international sites that have registered their institution will be included in a trial-specific survey.
Selection and Transparency
In the event that we receive qualified SARC trial participation requests from more sites than required and/or feasible, SARC’s Medical Officer and President & CEO together (in consultation with the study’s principal investigators) will make a final selection based on geographic distribution and access to the targeted patient populations. In addition, past participation and performance in SARC trials (if applicable) will be included among the selection factors. Sites that are qualified but are not selected to participate at this time will be noted by SARC and, subject to subsequent trial requirements, these sites will be favorably considered for participation in new studies.
SARC will maintain a database of the institutional membership information so that sites can be contacted with new trial opportunities. Annual updates will be requested from each institution.